Moonmuang, S.; Tantraworasin, A.; Orrapin, S.; Udomruk, S.; Chewaskulyong, B.; Pruksakorn, D.; Chaiyawat, P.
The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2023, 24, 4827.
https://doi.org/10.3390/ijms24054827
AMA Style
Moonmuang S, Tantraworasin A, Orrapin S, Udomruk S, Chewaskulyong B, Pruksakorn D, Chaiyawat P.
The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2023; 24(5):4827.
https://doi.org/10.3390/ijms24054827
Chicago/Turabian Style
Moonmuang, Sutpirat, Apichat Tantraworasin, Santhasiri Orrapin, Sasimol Udomruk, Busyamas Chewaskulyong, Dumnoensun Pruksakorn, and Parunya Chaiyawat.
2023. "The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer" International Journal of Molecular Sciences 24, no. 5: 4827.
https://doi.org/10.3390/ijms24054827
APA Style
Moonmuang, S., Tantraworasin, A., Orrapin, S., Udomruk, S., Chewaskulyong, B., Pruksakorn, D., & Chaiyawat, P.
(2023). The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 24(5), 4827.
https://doi.org/10.3390/ijms24054827
